Impact of failed mitral valve repair on hospital outcome of redo mitral valve procedures
Standard
Impact of failed mitral valve repair on hospital outcome of redo mitral valve procedures. / Onorati, Francesco; Gatti, Giuseppe; Perrotti, Andrea; Mariscalco, Giovanni; Reichart, Daniel; Milano, Aldo; Della Ratta, Ester; Rubino, Antonio; Santarpino, Giuseppe; Salsano, Antonio; Biancari, Fausto; Detter, Christian; Chocron, Sidney; Beghi, Cesare; De Feo, Marisa; Mignosa, Carmelo; Fischlein, Theodor; Pappalardo, Aniello; D'Errigo, Paola; Santini, Francesco; Faggian, Giuseppe.
In: EUR J CARDIO-THORAC, Vol. 51, No. 5, 01.05.2017, p. 906-912.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Impact of failed mitral valve repair on hospital outcome of redo mitral valve procedures
AU - Onorati, Francesco
AU - Gatti, Giuseppe
AU - Perrotti, Andrea
AU - Mariscalco, Giovanni
AU - Reichart, Daniel
AU - Milano, Aldo
AU - Della Ratta, Ester
AU - Rubino, Antonio
AU - Santarpino, Giuseppe
AU - Salsano, Antonio
AU - Biancari, Fausto
AU - Detter, Christian
AU - Chocron, Sidney
AU - Beghi, Cesare
AU - De Feo, Marisa
AU - Mignosa, Carmelo
AU - Fischlein, Theodor
AU - Pappalardo, Aniello
AU - D'Errigo, Paola
AU - Santini, Francesco
AU - Faggian, Giuseppe
N1 - © The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
PY - 2017/5/1
Y1 - 2017/5/1
N2 - OBJECTIVES: The prognostic impact of failed mitral valve repair (FMR) on in-hospital outcome after redo mitral valve surgery has not been thoroughly investigated.METHODS: Hospital outcomes after redo mitral valve surgery because of an FMR in patients from nine European centres were reported. Logistic regressions identified predictors of mortality in combined or isolated redo mitral valve operations. Hospital outcome was compared between propensity-matched cohorts with FMR and native mitral valves in the context of redo surgery and FMR versus failed prostheses.RESULTS: A total of 246 patients with FMR yielded a 6.5% mortality rate at redo surgery. FMR per se did not impact mortality at multivariable analysis ( P = 0.64). A preoperative Global Initiative for Chronic Obstructive Lung Disease (GOLD) score ≥2 chronic obstructive lung disease (COPD) (OR 15.2, P < 0.01), left ventricular ejection fraction <30% (odds ratio (OR) 21.5, P = 0.005), major injury to cardiovascular structures at re-entry (OR 27.2, P < 0.01) or injury to patent left internal mammary artery-coronary artery bypass graft (OR 7.6, P = 0.03) predicted mortality in the whole FMR population. GOLD ≥ 2 COPD (OR 12.3, P = 0.049), age at surgery (OR 1.15 for each incremental year, P = 0.049) and cardiopulmonary bypass duration (OR 1.02, P = 0.022) predicted mortality in isolated redo mitral valve surgery for FMR. The fourth (> 68 years = 13.8% mortality) and the fifth quintiles of age (≥73.4 years = 14.8%) reported the highest mortality (OR 3.8 and 4.2 respectively, P = 0.002) in this subgroup. Propensity-matched cohorts of FMR and native mitral valves in the context of redo surgery showed no differences in terms of mortality ( P = 0.69) and major morbidity (acute myocardial infarction P = 0.31, stroke P = 0.65, acute kidney injury P = 1.0), whereas more perioperative dialysis ( P = 0.04) and transfusions ( P = 0.02) were noted in propensity-matched failed prostheses compared to FMR.CONCLUSIONS: A failed mitral repair does not impact hospital outcome of redo surgery. Given the role of severe left ventricular dysfunction and advanced age on hospital mortality rates, an early indication for redo surgery may improve outcome.
AB - OBJECTIVES: The prognostic impact of failed mitral valve repair (FMR) on in-hospital outcome after redo mitral valve surgery has not been thoroughly investigated.METHODS: Hospital outcomes after redo mitral valve surgery because of an FMR in patients from nine European centres were reported. Logistic regressions identified predictors of mortality in combined or isolated redo mitral valve operations. Hospital outcome was compared between propensity-matched cohorts with FMR and native mitral valves in the context of redo surgery and FMR versus failed prostheses.RESULTS: A total of 246 patients with FMR yielded a 6.5% mortality rate at redo surgery. FMR per se did not impact mortality at multivariable analysis ( P = 0.64). A preoperative Global Initiative for Chronic Obstructive Lung Disease (GOLD) score ≥2 chronic obstructive lung disease (COPD) (OR 15.2, P < 0.01), left ventricular ejection fraction <30% (odds ratio (OR) 21.5, P = 0.005), major injury to cardiovascular structures at re-entry (OR 27.2, P < 0.01) or injury to patent left internal mammary artery-coronary artery bypass graft (OR 7.6, P = 0.03) predicted mortality in the whole FMR population. GOLD ≥ 2 COPD (OR 12.3, P = 0.049), age at surgery (OR 1.15 for each incremental year, P = 0.049) and cardiopulmonary bypass duration (OR 1.02, P = 0.022) predicted mortality in isolated redo mitral valve surgery for FMR. The fourth (> 68 years = 13.8% mortality) and the fifth quintiles of age (≥73.4 years = 14.8%) reported the highest mortality (OR 3.8 and 4.2 respectively, P = 0.002) in this subgroup. Propensity-matched cohorts of FMR and native mitral valves in the context of redo surgery showed no differences in terms of mortality ( P = 0.69) and major morbidity (acute myocardial infarction P = 0.31, stroke P = 0.65, acute kidney injury P = 1.0), whereas more perioperative dialysis ( P = 0.04) and transfusions ( P = 0.02) were noted in propensity-matched failed prostheses compared to FMR.CONCLUSIONS: A failed mitral repair does not impact hospital outcome of redo surgery. Given the role of severe left ventricular dysfunction and advanced age on hospital mortality rates, an early indication for redo surgery may improve outcome.
KW - Aged
KW - Female
KW - Heart Valve Prosthesis Implantation/adverse effects
KW - Hospital Mortality
KW - Humans
KW - Male
KW - Middle Aged
KW - Mitral Valve/surgery
KW - Mitral Valve Insufficiency/surgery
KW - Reoperation/mortality
KW - Retrospective Studies
KW - Treatment Outcome
U2 - 10.1093/ejcts/ezw436
DO - 10.1093/ejcts/ezw436
M3 - SCORING: Journal article
C2 - 28204140
VL - 51
SP - 906
EP - 912
JO - EUR J CARDIO-THORAC
JF - EUR J CARDIO-THORAC
SN - 1010-7940
IS - 5
ER -